Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/1476-4598-13-69.
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-12-01
|
| Series: | Molecular Cancer |
| Online Access: | https://doi.org/10.1186/s12943-022-01692-9 |
| _version_ | 1811302196686356480 |
|---|---|
| author | Barbara Nuvoli Sabrina Germoni Carlotta Morosetti Raffaela Santoro Giancarlo Cortese Serena Masi Iole Cordone Rossella Galati |
| author_facet | Barbara Nuvoli Sabrina Germoni Carlotta Morosetti Raffaela Santoro Giancarlo Cortese Serena Masi Iole Cordone Rossella Galati |
| author_sort | Barbara Nuvoli |
| collection | DOAJ |
| description | This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/1476-4598-13-69. |
| first_indexed | 2024-04-13T07:23:43Z |
| format | Article |
| id | doaj.art-8f85c7da5f924c1fa40ca7720a850f4a |
| institution | Directory Open Access Journal |
| issn | 1476-4598 |
| language | English |
| last_indexed | 2024-04-13T07:23:43Z |
| publishDate | 2022-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Molecular Cancer |
| spelling | doaj.art-8f85c7da5f924c1fa40ca7720a850f4a2022-12-22T02:56:32ZengBMCMolecular Cancer1476-45982022-12-012111110.1186/s12943-022-01692-9Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this diseaseBarbara Nuvoli0Sabrina Germoni1Carlotta Morosetti2Raffaela Santoro3Giancarlo Cortese4Serena Masi5Iole Cordone6Rossella Galati7Molecular Medicine Area, Regina Elena National Cancer InstituteS.A.F.U. Department, Regina Elena National Cancer InstituteMolecular Medicine Area, Regina Elena National Cancer InstituteMolecular Medicine Area, Regina Elena National Cancer InstituteS.A.F.U. Department, Regina Elena National Cancer InstituteClinical Pathology, Regina Elena National Cancer InstituteClinical Pathology, Regina Elena National Cancer InstituteMolecular Medicine Area, Regina Elena National Cancer InstituteThis article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/1476-4598-13-69.https://doi.org/10.1186/s12943-022-01692-9 |
| spellingShingle | Barbara Nuvoli Sabrina Germoni Carlotta Morosetti Raffaela Santoro Giancarlo Cortese Serena Masi Iole Cordone Rossella Galati Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease Molecular Cancer |
| title | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_full | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_fullStr | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_full_unstemmed | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_short | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_sort | retraction note exemestane blocks mesothelioma growth through downregulation of camp pcreb and cd44 implicating new treatment option in patients affected by this disease |
| url | https://doi.org/10.1186/s12943-022-01692-9 |
| work_keys_str_mv | AT barbaranuvoli retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT sabrinagermoni retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT carlottamorosetti retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT raffaelasantoro retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT giancarlocortese retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT serenamasi retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT iolecordone retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT rossellagalati retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease |